A citation-based method for searching scientific literature

Haruna Inoue, Mayuri Horiguchi, Kota Ono, Junko Kanoh. Nucleic Acids Res 2019
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Discovery and SAR of 5-(3-chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic acid (CX-4945), the first clinical stage inhibitor of protein kinase CK2 for the treatment of cancer.
Fabrice Pierre, Peter C Chua, Sean E O'Brien, Adam Siddiqui-Jain, Pauline Bourbon, Mustapha Haddach, Jerome Michaux, Johnny Nagasawa, Michael K Schwaebe, Eric Stefan,[...]. J Med Chem 2011
151
100

CK2 inhibitor CX-4945 suppresses DNA repair response triggered by DNA-targeted anticancer drugs and augments efficacy: mechanistic rationale for drug combination therapy.
Adam Siddiqui-Jain, Joshua Bliesath, Diwata Macalino, Mayuko Omori, Nanni Huser, Nicole Streiner, Caroline B Ho, Kenna Anderes, Chris Proffitt, Sean E O'Brien,[...]. Mol Cancer Ther 2012
68
100

UCSF Chimera--a visualization system for exploratory research and analysis.
Eric F Pettersen, Thomas D Goddard, Conrad C Huang, Gregory S Couch, Daniel M Greenblatt, Elaine C Meng, Thomas E Ferrin. J Comput Chem 2004
100

Mitotic read-out genes confer poor outcome in luminal A breast cancer tumors.
Javier Pérez-Peña, Ana Alcaraz-Sanabria, Cristina Nieto-Jiménez, Raquel Páez, Verónica Corrales-Sánchez, Leticia Serrano-Oviedo, Vikram B Wali, Gauri A Patwardhan, Eitan Amir, Balázs Győrffy,[...]. Oncotarget 2017
10
100

Distinct expression of CDCA3, CDCA5, and CDCA8 leads to shorter relapse free survival in breast cancer patient.
Nam Nhut Phan, Chih-Yang Wang, Kuan-Lun Li, Chien-Fu Chen, Chung-Chieh Chiao, Han-Gang Yu, Pung-Ling Huang, Yen-Chang Lin. Oncotarget 2018
39
100



Mechanisms of resistance to cisplatin and carboplatin.
David J Stewart. Crit Rev Oncol Hematol 2007
411
100

Pan-cancer analysis of genomic scar signatures associated with homologous recombination deficiency suggests novel indications for existing cancer drugs.
Andrea M Marquard, Aron C Eklund, Tejal Joshi, Marcin Krzystanek, Francesco Favero, Zhigang C Wang, Andrea L Richardson, Daniel P Silver, Zoltan Szallasi, Nicolai J Birkbak. Biomark Res 2015
90
100

Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy.
Janis M Taube, Alison Klein, Julie R Brahmer, Haiying Xu, Xiaoyu Pan, Jung H Kim, Lieping Chen, Drew M Pardoll, Suzanne L Topalian, Robert A Anders. Clin Cancer Res 2014
100


A new XRCC1-containing complex and its role in cellular survival of methyl methanesulfonate treatment.
Hao Luo, Doug W Chan, Tao Yang, Maria Rodriguez, Benjamin Ping-Chi Chen, Mei Leng, Jung-Jung Mu, David Chen, Zhou Songyang, Yi Wang,[...]. Mol Cell Biol 2004
113
100

CDCA3 promotes cell proliferation by activating the NF-κB/cyclin D1 signaling pathway in colorectal cancer.
Wei Zhang, Yanxia Lu, Xiaomin Li, Jianming Zhang, Lin Zheng, Wenjuan Zhang, Chun Lin, Weihao Lin, Xuenong Li. Biochem Biophys Res Commun 2018
17
100

11
100

Atomic structure of the APC/C and its mechanism of protein ubiquitination.
Leifu Chang, Ziguo Zhang, Jing Yang, Stephen H McLaughlin, David Barford. Nature 2015
131
100

MDC1 Interacts with TOPBP1 to Maintain Chromosomal Stability during Mitosis.
Pia-Amata Leimbacher, Samuel E Jones, Ann-Marie K Shorrocks, Mara de Marco Zompit, Matthew Day, Jordy Blaauwendraad, Diana Bundschuh, Sarah Bonham, Roman Fischer, Daniel Fink,[...]. Mol Cell 2019
24
100

TPX2/Aurora kinase A signaling as a potential therapeutic target in genomically unstable cancer cells.
Stephanie E van Gijn, Elles Wierenga, Nathalie van den Tempel, Yannick P Kok, Anne Margriet Heijink, Diana C J Spierings, Floris Foijer, Marcel A T M van Vugt, Rudolf S N Fehrmann. Oncogene 2019
18
100


Tome-1, a trigger of mitotic entry, is degraded during G1 via the APC.
Nagi G Ayad, Susannah Rankin, Monica Murakami, Judith Jebanathirajah, Steven Gygi, Marc W Kirschner. Cell 2003
123
100

Structural basis of CX-4945 binding to human protein kinase CK2.
Andrew D Ferguson, Payal R Sheth, Andrea D Basso, Sunil Paliwal, Kimberly Gray, Thierry O Fischmann, Hung V Le. FEBS Lett 2011
79
100

Expression of CDCA3 Is a Prognostic Biomarker and Potential Therapeutic Target in Non-Small Cell Lung Cancer.
Mark N Adams, Joshua T Burgess, Yaowu He, Kathy Gately, Cameron Snell, Shu-Dong Zhang, John D Hooper, Derek J Richard, Kenneth J O'Byrne. J Thorac Oncol 2017
25
100

Predicting responses to platin chemotherapy agents with biochemically-inspired machine learning.
Eliseos J Mucaki, Jonathan Z L Zhao, Daniel J Lizotte, Peter K Rogan. Signal Transduct Target Ther 2019
34
100


Overexpression of the E2F target gene CENPI promotes chromosome instability and predicts poor prognosis in estrogen receptor-positive breast cancer.
Pulari U Thangavelu, Cheng-Yu Lin, Srividya Vaidyanathan, Thu H M Nguyen, Eloise Dray, Pascal H G Duijf. Oncotarget 2017
19
100


The ABBA motif binds APC/C activators and is shared by APC/C substrates and regulators.
Barbara Di Fiore, Norman E Davey, Anja Hagting, Daisuke Izawa, Jörg Mansfeld, Toby J Gibson, Jonathon Pines. Dev Cell 2015
97
100

Ultradeep human phosphoproteome reveals a distinct regulatory nature of Tyr and Ser/Thr-based signaling.
Kirti Sharma, Rochelle C J D'Souza, Stefka Tyanova, Christoph Schaab, Jacek R Wiśniewski, Jürgen Cox, Matthias Mann. Cell Rep 2014
510
100

Absolute quantification of somatic DNA alterations in human cancer.
Scott L Carter, Kristian Cibulskis, Elena Helman, Aaron McKenna, Hui Shen, Travis Zack, Peter W Laird, Robert C Onofrio, Wendy Winckler, Barbara A Weir,[...]. Nat Biotechnol 2012
100

Multiomic Analysis of the UV-Induced DNA Damage Response.
Stefan Boeing, Laura Williamson, Vesela Encheva, Ilaria Gori, Rebecca E Saunders, Rachael Instrell, Ozan Aygün, Marta Rodriguez-Martinez, Juston C Weems, Gavin P Kelly,[...]. Cell Rep 2016
82
100

Improved side-chain torsion potentials for the Amber ff99SB protein force field.
Kresten Lindorff-Larsen, Stefano Piana, Kim Palmo, Paul Maragakis, John L Klepeis, Ron O Dror, David E Shaw. Proteins 2010
100

Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer.
Melinda L Telli, Kirsten M Timms, Julia Reid, Bryan Hennessy, Gordon B Mills, Kristin C Jensen, Zoltan Szallasi, William T Barry, Eric P Winer, Nadine M Tung,[...]. Clin Cancer Res 2016
307
100

The protein kinase CK2 facilitates repair of chromosomal DNA single-strand breaks.
Joanna I Loizou, Sherif F El-Khamisy, Anastasia Zlatanou, David J Moore, Douglas W Chan, Jun Qin, Stefania Sarno, Flavio Meggio, Lorenzo A Pinna, Keith W Caldecott. Cell 2004
246
100

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
100

MRE11 stability is regulated by CK2-dependent interaction with R2TP complex.
P von Morgen, K Burdova, T G Flower, N J O'Reilly, S J Boulton, S J Smerdon, L Macurek, Z Hořejší. Oncogene 2017
21
100

Pharmacologic inhibition of the anaphase-promoting complex induces a spindle checkpoint-dependent mitotic arrest in the absence of spindle damage.
Xing Zeng, Frederic Sigoillot, Shantanu Gaur, Sungwoon Choi, Kathleen L Pfaff, Dong-Chan Oh, Nathaniel Hathaway, Nevena Dimova, Gregory D Cuny, Randall W King. Cancer Cell 2010
215
100

Genome-wide transcriptome profiling of homologous recombination DNA repair.
Guang Peng, Curtis Chun-Jen Lin, Wei Mo, Hui Dai, Yun-Yong Park, Soo Mi Kim, Yang Peng, Qianxing Mo, Stefan Siwko, Ruozhen Hu,[...]. Nat Commun 2014
115
100

CX-4945, an orally bioavailable selective inhibitor of protein kinase CK2, inhibits prosurvival and angiogenic signaling and exhibits antitumor efficacy.
Adam Siddiqui-Jain, Denis Drygin, Nicole Streiner, Peter Chua, Fabrice Pierre, Sean E O'Brien, Josh Bliesath, Mayuko Omori, Nanni Huser, Caroline Ho,[...]. Cancer Res 2010
324
100

Integrated proteomic analysis of post-translational modifications by serial enrichment.
Philipp Mertins, Jana W Qiao, Jinal Patel, Namrata D Udeshi, Karl R Clauser, D R Mani, Michael W Burgess, Michael A Gillette, Jacob D Jaffe, Steven A Carr. Nat Methods 2013
349
100

Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 2. Explicit Solvent Particle Mesh Ewald.
Romelia Salomon-Ferrer, Andreas W Götz, Duncan Poole, Scott Le Grand, Ross C Walker. J Chem Theory Comput 2013
100

Breathing New Life into the Mechanisms of Platinum Resistance in Lung Adenocarcinoma.
Alvaro Gonzalez-Rajal, Jordan F Hastings, D Neil Watkins, David R Croucher, Andrew Burgess. Front Cell Dev Biol 2020
5
100

Cancer statistics, 2019.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2019
100


Genome-wide expression screens indicate a global role for protein kinase CK2 in chromatin remodeling.
Thomas Barz, Karin Ackermann, Gaelle Dubois, Roland Eils, Walter Pyerin. J Cell Sci 2003
58
100

Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer.
Kenneth R Hess, Keith Anderson, W Fraser Symmans, Vicente Valero, Nuhad Ibrahim, Jaime A Mejia, Daniel Booser, Richard L Theriault, Aman U Buzdar, Peter J Dempsey,[...]. J Clin Oncol 2006
472
100

Chromosome arm aneuploidies shape tumour evolution and drug response.
Ankit Shukla, Thu H M Nguyen, Sarat B Moka, Jonathan J Ellis, John P Grady, Harald Oey, Alexandre S Cristino, Kum Kum Khanna, Dirk P Kroese, Lutz Krause,[...]. Nat Commun 2020
15
100

CDCA3 mediates p21-dependent proliferation by regulating E2F1 expression in colorectal cancer.
Wenwei Qian, Zhiyuan Zhang, Wen Peng, Jie Li, Qiou Gu, Dongjian Ji, Qingyuan Wang, Yue Zhang, Bing Ji, Sen Wang,[...]. Int J Oncol 2018
18
100

PrDOS: prediction of disordered protein regions from amino acid sequence.
Takashi Ishida, Kengo Kinoshita. Nucleic Acids Res 2007
438
100


Protein Kinase CK2: Intricate Relationships within Regulatory Cellular Networks.
Teresa Nuñez de Villavicencio-Diaz, Adam J Rabalski, David W Litchfield. Pharmaceuticals (Basel) 2017
37
100

One-thousand-and-one substrates of protein kinase CK2?
Flavio Meggio, Lorenzo A Pinna. FASEB J 2003
998
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.